| Calcium Supplements Strategy for Kidney Stones Prevention in Crohn's Patients (NCT01735461) | University of British Columbia | 2012-12-01 |
| The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation (NCT01078935) | The Baruch Padeh Medical Center, Poriya | 2012-12-01 |
| Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea. (NCT01731665) | Asan Medical Center | 2012-12-01 |
| Clinical Course of Korean Crohn's Disease Cohort (NCT01554007) | Kyunghee University Medical Center | 2012-12-01 |
| Comparison of Standard and Low Dose CT Enterography for Crohn's Disease (NCT01736046) | University of British Columbia | 2012-12-01 |
| Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission (NCT01820247) | Zhu Weiming | 2012-12-01 |
| PET/CT to Predict Response to Infliximab Therapy in Patients With Crohn's Disease (NCT01759017) | Brigham and Women's Hospital | 2012-12-01 |
| Oxidative Stress and Inflammation Caused by Intravenous Iron in Crohn's Disease Patients With Iron Deficiency Anemia (NCT01823029) | Jinling Hospital, China | 2012-11-01 |
| Multimodal Approach in IBD Patients (NCT01705522) | Clinical Hospital Colentina | 2012-10-01 |
| OPERA Database - Crohn's Protocol (NCT01720368) | Dartmouth-Hitchcock Medical Center | 2012-10-01 |
| The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD) (NCT01823042) | Jinling Hospital, China | 2012-10-01 |
| Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants (NCT01562951) | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 2012-10-01 |
| Bioavailability of Vitamin D in Children and Adolescents With Crohn's Disease (NCT01692808) | St. Justine's Hospital | 2012-10-01 |
| Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease (NCT01596894) | Prof. Arie Levine | 2012-10-01 |
| Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) (NCT01692743) | University of Maryland, Baltimore | 2012-09-01 |
| Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's Disease (NCT01697761) | Shanghai Institute of Acupuncture, Moxibustion and Meridian | 2012-09-01 |
| Ultrasound Stiffness Imaging in Crohn's Disease (NCT01666626) | University of Michigan | 2012-09-01 |
| FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) (NCT01676324) | University of British Columbia | 2012-09-01 |
| A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Patients With Crohn's Disease (NCT01632462) | Federico II University | 2012-09-01 |
| Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo (NCT01576471) | Coronado Biosciences, Inc. | 2012-07-01 |
| A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease. (NCT01659762) | Emory University | 2012-07-01 |
| Autologous Stem Cell Transplantation for Crohn's Disease (NCT00692939) | Paul Szabolcs | 2012-06-26 |
| Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease (NCT01545050) | CSL Behring | 2012-06-01 |
| PillCam® Platform With the PillCam Crohn's Disease Capsule (NCT01631435) | Medtronic - MITG | 2012-06-01 |
| Energy Expenditure in Patients With Crohn's Disease (NCT01622270) | Tel-Aviv Sourasky Medical Center | 2012-06-01 |
| The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy (NCT01181765) | Janssen Inc. | 2012-06-01 |
| Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease (NCT01564823) | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 2012-06-01 |
| A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease (NCT01635621) | UCB BIOSCIENCES GmbH | 2012-06-01 |
| Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease (NCT01442025) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2012-06-01 |
| Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs (NCT01387594) | Shire | 2012-05-03 |
| Dual Energy Computerized Tomography (DE-CT) in Patients With Crohn's Disease (NCT02341755) | Shaare Zedek Medical Center | 2012-05-01 |
| Psychology of Crohn's Disease (NCT01573078) | University of British Columbia | 2012-05-01 |
| Perfusion Assessment in Laparoscopic Left Anterior Resection (NCT01560377) | Novadaq Technologies ULC, now a part of Stryker | 2012-05-01 |
| CAre of Patients With PArenteral Nutrition At Home (NCT01545063) | KU Leuven | 2012-05-01 |
| Vitamin D Supplementation in Adult Crohn's Disease (NCT01369667) | University of Dublin, Trinity College | 2012-04-01 |
| Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease (NCT01749813) | Stanford University | 2012-04-01 |
| Adalimumab-psoriasis and Small Bowel Lesions (NCT01556672) | Innovaderm Research Inc. | 2012-04-01 |
| Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD) (NCT01524120) | University of Erlangen-Nürnberg Medical School | 2012-04-01 |
| Vagus Nerve Stimulation a New Approach in the Treatment of Crohn's Disease (NCT01569503) | University Hospital, Grenoble | 2012-03-01 |
| OTIS Cimzia Pregnancy Registry (NCT01797224) | University of California, San Diego | 2012-03-01 |
| Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease (NCT01647412) | Columbia University | 2012-03-01 |
| Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients. (NCT01957423) | University of Campinas, Brazil | 2012-03-01 |
| Personality Traits and Its Impact on Quality of Life and Clinical Outcome Evaluation in Crohn's Patients (NCT01887548) | Jinling Hospital, China | 2012-03-01 |
| The Safety And Efficacy Of Maintenance Therapy With CP-690,550 (NCT01393899) | Pfizer | 2012-03-01 |
| Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients (NCT01576120) | Medtronic - MITG | 2012-03-01 |
| Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study (NCT02450513) | Universitaire Ziekenhuizen KU Leuven | 2012-03-01 |
| Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan (NCT01514240) | AstraZeneca | 2012-02-01 |
| Improving Medication Adherence in Pediatric Inflammatory Bowel Disease (NCT01536509) | Children's Hospital Medical Center, Cincinnati | 2012-02-01 |
| Anticipation Effect on Painful Phenomenons Linked to Rectal Distension for Patients With a Crohn's Disease in Remission (NCT02874495) | University Hospital, Grenoble | 2012-01-01 |
| Special Investigation (Long-term Investigation) in Patients With Crohn's Disease (NCT01464333) | AbbVie (prior sponsor, Abbott) | 2011-12-16 |
| Efficacy Study of Pneumococcal Vaccination in Crohn's Disease (NCT01505855) | Kyunghee University Medical Center | 2011-12-01 |
| Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease (NCT01466374) | Bristol-Myers Squibb | 2011-12-01 |
| Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) (NCT01496053) | Oslo University Hospital | 2011-12-01 |
| Safety and Maintenance Study of Entocort for Children With Crohn's Disease (NCT01453946) | Padagis LLC | 2011-12-01 |
| Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate (NCT01991314) | Queen Mary University of London | 2011-12-01 |
| Vitd and Barrier Function in IBD (NCT01792388) | University of Dublin, Trinity College | 2011-12-01 |
| An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease (NCT01536418) | GlaxoSmithKline | 2011-11-11 |
| Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease (NCT01434693) | Coronado Biosciences, Inc. | 2011-11-01 |
| Safety Study of Entocort for Children With Crohn's Disease (NCT01444092) | Padagis LLC | 2011-11-01 |
| Disease Course in an IBD Cohort in the Era of Biological Treatment (NCT01468090) | Hvidovre University Hospital | 2011-10-01 |
| Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas (NCT01635543) | University of British Columbia | 2011-10-01 |
| A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects (NCT01489943) | GlaxoSmithKline | 2011-09-19 |
| A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) (NCT01369355) | Janssen Research & Development, LLC | 2011-09-13 |
| A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease (NCT01388933) | Tsumura USA | 2011-09-01 |
| Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD) (NCT01577264) | UCB Pharma | 2011-08-01 |
| Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) (NCT01352221) | Shield Therapeutics | 2011-08-01 |
| Endomicroscopy for Assessment of Mucosal Healing (NCT01417715) | University of Erlangen-Nürnberg Medical School | 2011-08-01 |
| Endoscopy for Assessment of Mucosal Healing in IBD (NCT01417702) | University of Erlangen-Nürnberg Medical School | 2011-08-01 |
| A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2) (NCT01369342) | Janssen Research & Development, LLC | 2011-07-01 |
| A Study To Monitor Long-Term Treatment With PF-00547659 (NCT01298492) | Shire | 2011-07-01 |
| A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1) (NCT01369329) | Janssen Research & Development, LLC | 2011-07-01 |
| Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease (NCT01392365) | Asan Medical Center | 2011-07-01 |
| A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients (NCT01355614) | Novartis Pharmaceuticals | 2011-06-01 |
| A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease (NCT02550158) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2011-06-01 |
| CT Diagnoses in Crohn"s Disease Activity (NCT04956991) | Peking University Third Hospital | 2011-06-01 |
| GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease (NCT01316939) | GlaxoSmithKline | 2011-05-09 |
| Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) (NCT01346826) | Asan Medical Center | 2011-05-01 |
| Endomicroscopy in IBD Patients (NCT01417728) | University of Erlangen-Nürnberg Medical School | 2011-05-01 |
| Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease (NCT01276509) | Shire | 2011-04-06 |
| A Study of TRK-170 for the Treatment of Crohn's Disease (NCT01345799) | Toray Industries, Inc | 2011-04-01 |
| Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences (NCT02883296) | Central Hospital, Nancy, France | 2011-04-01 |
| Open-Label Extension Study of GSK1605786A (NCT01318993) | GlaxoSmithKline | 2011-04-01 |
| Switching From Adalimumab to Infliximab (NCT01338740) | University Hospital, Ghent | 2011-04-01 |
| Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients (NCT01341808) | Asan Medical Center | 2011-04-01 |
| Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease (NCT01349504) | Beth Israel Deaconess Medical Center | 2011-04-01 |
| Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. (NCT01517516) | University of California, Los Angeles | 2011-03-01 |
| Multiple Ascending Doses of AMG 139 in Healthy and Crohn's Disease Subjects (NCT01258205) | AstraZeneca | 2011-02-28 |
| Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease (NCT01235689) | AbbVie (prior sponsor, Abbott) | 2011-02-11 |
| Long-term Safety Study of Brodalumab in Adults With Crohn's Disease (NCT01199302) | Amgen | 2011-02-02 |
| Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease (NCT01203631) | Janssen Research & Development, LLC | 2011-02-01 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. (NCT01290042) | Amgen | 2011-02-01 |
| Clinical Efficacy of TNFa Kinoid in Crohn's Disease Patients (NCT01291810) | Neovacs | 2011-02-01 |
| Use of PET-CT in the Management of Crohn's Disease (NCT01182467) | Columbia University | 2011-02-01 |
| A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy (NCT01287897) | Pfizer | 2011-02-01 |
| Chondroitin Sulfate for Crohn's Disease (NCT01245088) | University Hospitals Cleveland Medical Center | 2011-01-01 |
| Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut (NCT01275508) | University of Erlangen-Nürnberg Medical School | 2011-01-01 |
| A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576 in the Treatment of Perinanal Fistulas in Patients Suffering From Crohn's Disease (NCT01316601) | Gerhard Rogler | 2011-01-01 |
| A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease (NCT01277666) | GlaxoSmithKline | 2010-12-20 |
| The Clinical Utility of Fecal Caprotectin and Lactoferrin in Patients Undergoing Capsular Endoscopy (NCT01266629) | Shaare Zedek Medical Center | 2010-12-01 |
| Infliximab, Regulatory T Cells, IL2 and Crohn's Disease (NCT01266785) | Oregon Health and Science University | 2010-12-01 |